A recently evolved novel trophoblast-enriched secreted form of fms-like tyrosine kinase-1 variant is up-regulated in hypoxia and preeclampsia.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/jc.2009-0017PMID 19336504PMCID PMC2708964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel Biomarkers for Predicting Preeclampsia

  2008cited by this paper
• Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.

  2008cited by this paper
• Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

  2008cited by this paper
• Molecular mechanisms of preeclampsia.

  2008cited by this paper
• A Novel Human-Specific Soluble Vascular Endothelial Growth Factor Receptor 1: Cell Type-Specific Splicing and Implications to Vascular Endothelial Growth Factor Homeostasis and Preeclampsia

  2008cited by this paper
• Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.

  2008cited by this paper
• Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

  2008cited by this paper
• Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

  2007cited by this paper
• Trophoblast biology, responses to hypoxia and placental dysfunction in preeclampsia.

  2007cited by this paper
• Intronic polyadenylation signal sequences and alternate splicing generate human soluble Fltl variants and regulate the abundance of soluble Flt1 in the placenta

  2007cited by this paper
• Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression

  2007cited by this paper
• The UCSC Genome Browser Database: 2008 update

  2007cited by this paper
• Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

  2007cited by this paper
• Dysregulation of the Circulating and Tissue-Based Renin–Angiotensin System in Preeclampsia

  2007cited by this paper
• Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

  2006cited by this paper
• Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis.

  2006cited by this paper
• Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta.

  2005cited by this paper
• Circulating angiogenic factors and the risk of preeclampsia.

  2004cited by this paper
• Standardized nomenclature for Alu repeats

  2004cited by this paper
• Elevated Placental Soluble Vascular Endothelial Growth Factor Receptor-1 Inhibits Angiogenesis in Preeclampsia

  2004cited by this paper
• ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes

  2004cited by this paper
• Antibiotic use in relation to the risk of breast cancer

  2004cited by this paper
• Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies.

  2004cited by this paper
• Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia.

  2004cited by this paper
• Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria*

  2003cited by this paper
• VEGF receptor signal transduction.

  2003cited by this paper
• Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

  2003cited by this paper
• VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis

  2003cited by this paper
• Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome.

  2002cited by this paper
• Adriana and Luisa Castellucci Award lecture 2001. Hypoxia inducible factor-1: oxygen regulation of trophoblast differentiation in normal and pre-eclamptic pregnancies--a review.

  2002cited by this paper
• Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies.

  2001cited by this paper
• VEGF Receptor Signal Transduction

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

  1999cited by this paper
• Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta.

  1999cited by this paper
• Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors.

  1998cited by this paper
• Colocalisation of vascular endothelial growth factor and its Flt-1 receptor in human placenta.

  1995cited by this paper
• Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells.

  1994cited by this paper
• Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

  1993cited by this paper
• Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei.

  1990cited by this paper
• Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

  1986cited by this paper
• Word Count: 4,574 Correspondence and Print Requests to:

  year unknowncited by this paper

• The role of the FLT1 gene alternative splicing in the fetal growth retardation development

  2026cites this paper
• The multifactorial role of HDAC9 at the maternal–fetal interface in the pathogenesis of preeclampsia

  2025cites this paper
• Shehata Marker: A Promising Tool for Assessing Graft Endothelial Dysfunction and Hypoxic Injury

  2025cites this paper
• Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications

  2024cites this paper
• Preeclamptic serum and soluble fms-like tyrosine kinase-1 suppress endothelial inward rectifier potassium currents.

  2024cites this paper
• CRISPR/Cas9-mediated mutations in both a cAMP response element and an ETS-binding site suppress FLT1 gene expression.

  2023cites this paper
• Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.

  2022cites this paper
• Neuro-oncological Ventral Antigen 2 Regulates Splicing of Vascular Endothelial Growth Factor Receptor 1 and Is Required for Endothelial Function

  2022cites this paper
• Pathogenetic Approach to Early Preeclampsia and the Feasibility of Pregnancy Prolongation

  2022cites this paper
• Induction of the PPARγ (Peroxisome Proliferator-Activated Receptor γ)-GCM1 (Glial Cell Missing 1) Syncytialization Axis Reduces sFLT1 (Soluble fms-Like Tyrosine Kinase 1) in the Preeclamptic Placenta

  2021cites this paper
• Non-viral gene delivery utilizing RALA modulates sFlt-1 secretion, important for preeclampsia.

  2021cites this paper
• A simple detection method for the serum sFLT1 protein in preeclampsia

  2021cites this paper
• Reduction of serum-induced endothelial STAT3(Y705) activation is associated with preeclampsia.

  2021cites this paper
• Vascular Dysfunction in Preeclampsia

  2021cites this paper
• Modelling preeclampsia: a comparative analysis of the common human trophoblast cell lines

  2020cites this paper
• Renal biomarkers of preeclampsia

  2020cites this paper
• A VEGF-A/SOX2/SRSF2 network controls VEGFR1 pre-mRNA alternative splicing in lung carcinoma cells

  2019cites this paper
• EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion

  2019cites this paper
• The Immunogenetic Conundrum of Preeclampsia

  2018cites this paper
• Soluble FLT-1 rules placental destiny.

  2018cites this paper
• Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.

  2018cites this paper
• HIF-2α, but not HIF-1α, mediates hypoxia-induced up-regulation of Flt-1 gene expression in placental trophoblasts

  2018cites this paper
• VEGF-A selectively inhibits FLT1 ectodomain shedding independent of receptor activation and receptor endocytosis.

  2018cites this paper
• Pro-angiogenic therapeutics for preeclampsia

  2018cites this paper
• The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

  2018cites this paper
• Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia.

  2018cites this paper
• Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1

  2018cites this paper
• Soluble Fms-Like Tyrosine Kinase 1 (sFlt-1) and Risk of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.

  2017cites this paper
• A Two-Pronged Approach to Preeclampsia: Understanding Gene Expression and Targeting sFlt1 using RNAi

  2017cites this paper
• FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia

  2017cites this paper
• Splice Variants of the RTK Family: Their Role in Tumour Progression and Response to Targeted Therapy

  2017cites this paper
• Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia

  2017cites this paper
• Ectodomain cleavage of FLT1 regulates receptor activation and function and is not required for its downstream intracellular cleavage.

  2016cites this paper
• Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis

  2016cites this paper
• Evidence-Based Revised View of the Pathophysiology of Preeclampsia.

  2016cites this paper
• Differential Impact of VEGF and FGF2 Signaling Mechanisms on Flt1 Pre-mRNA Splicing

  2016cites this paper
• Altered Level of Soluble fms-like Tyrosine Kinase 1 ( sFlt 1 ) and Hypoxia Inducible Factor-1 α ( HIF-1 α ) in Normotensive Pregnancy and Preeclampsia

  2016cites this paper
• Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production1

  2016cites this paper
• Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity

  2015cites this paper
• Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1.

  2015influential citation
• Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice

  2015influential citation
• Oxidative stress in preeclampsia and the role of free fetal hemoglobin

  2015cites this paper
• Maternal and Fetoplacental Hypoxia Do Not Alter Circulating Angiogenic Growth Effectors During Human Pregnancy1

  2014cites this paper
• Hypoxic Trophoblast HMGB1 Induces Endothelial Cell Hyperpermeability via the TRL-4/Caveolin-1 Pathway

  2014cites this paper
• Variability in mRNA expression of fms-like tyrosine kinase-1 variants in normal and preeclamptic placenta

  2014cites this paper
• In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy

  2014cites this paper
• Unlocking Doors without Keys: Activation of Src by Truncated C-terminal Intracellular Receptor Tyrosine Kinases Lacking Tyrosine Kinase Activity

  2014cites this paper
• Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.

  2014cites this paper
• TRL-4/Caveolin-1 Pathway Endothelial Cell Hyperpermeability via the Hypoxic Trophoblast HMGB1 Induces

  2014cites this paper
• Significancia del desbalance de los factores angiogénicos en preeclampsia

  2014cites this paper
• Exercise‐Induced Capillary Growth in Human Skeletal Muscle and the Dynamics of VEGF

  2014cites this paper
• N-Terminal Cleavage and Release of the Ectodomain of Flt1 Is Mediated via ADAM10 and ADAM 17 and Regulated by VEGFR2 and the Flt1 Intracellular Domain

  2014cites this paper
• Altered Level of Soluble fms-like Tyrosine Kinase 1 (sFlt1) and Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Normotensive Pregnancy and Preeclampsia

  2013cites this paper
• Control of Human Endometrial Stromal Cell Motility by PDGF-BB, HB-EGF and Trophoblast-Secreted Factors

  2013cites this paper
• A leading role for the immune system in the pathophysiology of preeclampsia

  2013cites this paper
• Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist.

  2013cites this paper
• INHIBITORY EFFECT OF EICOSAPENTAENOIC ACID (EPA) ON SFLT-1 (SOLUBLE VEGF RECEPTOR-1) EXPRESSION IN TROPHOBLAST TUMOR CELL LINE JEG-3

  2013cites this paper
• Evidence for extraplacental sources of circulating angiogenic growth effectors in human pregnancy.

  2013cites this paper
• Hypertension and Kidney Disease in Pregnancy

  2012cites this paper
• MINIREVIEW The Role of Hypoxia and Hypoxia-inducible Factor-1α in Preeclampsia Pathogenesis

  2012cites this paper
• Molecular genetics of preeclampsia and HELLP syndrome - a review.

  2012cites this paper
• Coordinated DNA methylation and gene expression changes in smoker alveolar macrophages: specific effects on VEGF receptor 1 expression

  2012cites this paper
• The Pathophysiology of Preeclampsia Involves Altered Levels of Angiogenic Factors Promoted by Hypoxia and Autoantibody-Mediated Mechanisms1

  2012cites this paper
• MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

  2012cites this paper
• Secretion of Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1/sFlt1) Requires Arf1, Arf6, and Rab11 GTPases

  2012influential citation
• Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia.

  2012cites this paper
• The Role of Hypoxia and Hypoxia-Inducible Factor-1Alpha in Preeclampsia Pathogenesis

  2012cites this paper
• Placental expression of a novel primate‐specific splice variant of sFlt‐1 is upregulated in pregnancies complicated by severe early onset pre‐eclampsia

  2011cites this paper
• Preeclampsia and the Anti-Angiogenic State.

  2011cites this paper
• Expression of Placental FLT 1 Transcript Variants Relates to Both Gestational Hypertensive Disease and Fetal Growth

  2011cites this paper
• Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression.

  2011cites this paper
• Expression of Placental FLT1 Transcript Variants Relates to Both Gestational Hypertensive Disease and Fetal Growth

  2011cites this paper
• Angiogenic factors and preeclampsia.

  2011cites this paper
• Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease

  2011cites this paper
• Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1

  2011cites this paper
• Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.

  2010cites this paper
• Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation

  2010cites this paper
• The Effects of Hemodynamic Force on Embryonic Development

  2010cites this paper
• Lysophosphatidic acid up-regulates expression of growth-regulated oncogene-alpha, interleukin-8, and monocyte chemoattractant protein-1 in human first-trimester trophoblasts: possible roles in angiogenesis and immune regulation.

  2010cites this paper
• Alternative splicing: a promising target for pharmaceutical inhibition of pathological angiogenesis?

  2010cites this paper
• A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use

  2009cites this paper
• Preeclampsia and soluble fms-like tyrosine kinase 1.

  2009cites this paper